Biotech

All Articles

A better take a look at Tough Biotech's Ferocious 15

.Within this week's episode of "The Top Pipe," our team are actually diving in to Fierce Biotech's y...

Lilly experiences phase 2 breakdown of tau-targeting med

.The confetti is actually still flying from Eli Lilly's party commemorating the commendation of Alzh...

Biogen CMO Maha Radhakrishnan participates in Sofinnova-- Chutes &amp Ladders

.Accept to this week's Chutes &amp Ladders, our roundup of considerable management hirings, shooting...

Lykos will inquire FDA to reconsider its decision adhering to being rejected of MDMA treatment for post-traumatic stress disorder

.Adhering to an unsatisfactory showing for Lykos Rehabs' MDMA candidate for post-traumatic stress di...

AN 2 fifty percents head count, ceases stage 3 test after information let down

.AN2 Therapeutics is actually rethinking its service in response to uninspired midphase records, vow...

Merck pays $700M for bispecific, snooping autoimmune opening and also chance to test Amgen in cancer cells

.Merck &amp Co. is actually paying out $700 thousand ahead of time to challenge Amgen in a blood str...

Gilead pays for J&ampJ $320M to leave licensing offer for seladelpar

.With Gilead Sciences almost an FDA choice for its liver ailment drug seladelpar, the provider has a...

' All palms on deck' at Lilly as peers target being overweight market

.CEO David Ricks can find the providers establishing outdoors tents at basecamp behind Eli Lilly in ...

Entero giving up workers, leaving office and pausing R&ampD

.Mattress Liquidators has actually transformed Entero Therapeutics white as a sheet. The creditor or...

Exelixis drops ADC after deciding it is actually no suit for Tivdak

.Exelixis is actually losing hope on its own cells variable (TF)- targeting antibody-drug conjugate ...